Rutgers, The State University of New Jersey
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rutgers, The State University of New Jersey sits in the top decile of US sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count).
Rutgers, The State University of New Jersey: 413 sponsored US clinical trials, 109 recruiting.
Rutgers, The State University of New Jersey sponsors 413 registered US clinical trials on ClinicalTrials.gov, 109 of them currently recruiting, and 196 completed. 35 of these trials are in Phase 3-4 (later-stage) and 104 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 6 trials.
Top-decile sponsor footprint
Rutgers, The State University of New Jersey ranks in the top decile of sponsors by registered trial count (#86 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
196 of 267 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
413 total, page 2 of 9
Identify the Optimal TMS Pulse Protocol to Modulate Reward Activity
NCT06695884
Brain Criticality, Oculomotor Control, and Cognitive Effort
NCT06344559
Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant
NCT06609980
Addressing Genomic Disparities in Cancer Survivors
NCT06073626
Craving & Decision-Making
NCT06440577
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
NCT06555094
Vibratory Stimulation to Improve Balance Recovery
NCT05702801
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice
NCT06131021
Rutgers University Study of the Genetics of Breast Cancer.
NCT06773897
Lung Function Monitoring During Hypoxemia Episodes
NCT06535074
Twin Block, Pain Medications and Third Molar Extractions
NCT04880707
Modulating Reward Learning Using Transcranial Magnetic Stimulation
NCT06323057
Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)
NCT06307028
Liver Transplantation in Intrahepatic Cholangiocarcinoma
NCT06140134
YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility
NCT05815017
The Computational and Neural Mechanisms Linking Decision-making and Memory in Humans
NCT06072378
Motivational Refinements for Facilitating Reinforcement Schedule Thinning
NCT05790668
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
NCT06033599
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
NCT06032559
Influence of Short-Term Antibiotic Therapy on Exercise
NCT05961189
Basic and Applied Research on Extinction Bursts
NCT05925101
Internet Assisted Career-Oriented Soft-skills Training for Transition Age Youth with Mental Health Conditions
NCT05766280
HealthyWE: Achieving a Healthy Weight and Reducing Pain
NCT07095673
Lymphatic System Stimulation in Heart Failure
NCT05834400
Melatonin for Prevention of Kidney Injury
NCT05084196
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
NCT05806931
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
NCT04802291
Exercise to Improve Brain Health in Older African Americans
NCT05597124
High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)
NCT05589181
Identify the Optimal TMS Target to Modulate Reward Activity
NCT05766254
Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation
NCT05801861
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas
NCT05419518
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
NCT05373823
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
NCT05703425
TELESCOPE- TELEhealth Shared Decision-making COaching
NCT05491213
The Role of Macrophage Activation in Lung Injury Following Ozone Exposure
NCT05794087
Extensions of Resurgence as Choice
NCT05537610
Characterization of the Temporo-masseteric Nerve Block (TMNB) in Healthy Subjects
NCT05507164
History of Neonatology
NCT06176950
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
NCT05559164
Reducing Pain From Wisdom Molar Extractions
NCT05335070
IVIG vs SCIG in CIDP
NCT05584631
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
NCT05366829
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
NCT05332002
Behavioral Exposure for Introceptive Tolerance RCT
NCT05398276
ATATcH Alternating Treatment Plans for Advanced Cancer
NCT05358548
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
NCT05040711
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
NCT04211259
Emergent Multi-Class Imitation Training
NCT05849376
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
NCT05296421
What is open in the Rutgers, The State University of New Jersey pipeline
109 recruiting of 413 indexed (26% open); 196 completed (47%).
Phase mix: 35 late (III/IV) vs 104 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rutgers, The State University of New Jersey: open-pipeline peers nationwide
Peers matched on 413 registered trials and 26% open enrollment, not the therapeutic-area sidebar.
Rutgers, The State University of New Jersey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 413 trials (± recruiting share)
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
- Takeda · 408 trials · 12% recruiting
- University of Kansas Medical Center · 408 trials · 23% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
Sponsors near 26% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this Rutgers, The State University of New Jersey page
413 registered trials is a research-attention snapshot, not an endorsement of Rutgers, The State University of New Jersey or any single study.
- 109 of Rutgers, The State University of New Jersey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Rutgers, The State University of New Jersey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rutgers, The State University of New Jersey pipeline card: 413 registered trials from official public datasets.Report a data error.